Skip to main content

HYDROCHLOROTHIAZIDE

NDC 69315-155 · Leading Pharma, LLC

Generic nameHYDROCHLOROTHIAZIDE
Dosage formTABLET
RouteORAL
Active ingredient(s)HYDROCHLOROTHIAZIDE
Strength12.5 mg/1
Pharmacologic classIncreased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

69315-155-01 — 100 TABLET in 1 BOTTLE, PLASTIC (69315-155-01)

69315-155-10 — 1000 TABLET in 1 BOTTLE, PLASTIC (69315-155-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69097-828 — quinapril and Hydrochlorothiazide 10/12.5, 69097-829 — Quinapril and Hydrochlorothiazide 20/12.5, 69097-831 — Quinapril and Hydrochlorothiazide 20/25, 69097-968 — Lisinopril and Hydrochlorothiazide Tablets, 69097-969 — Lisinopril and Hydrochlorothiazide Tablets, 69097-971 — Lisinopril and Hydrochlorothiazide Tablets, 69097-972 — Fosinopril Sodium and Hydrochlorothiazide, 69097-973 — Fosinopril Sodium and Hydrochlorothiazide, 69315-130 — HYDROCHLOROTHIAZIDE, 69315-131 — HYDROCHLOROTHIAZIDE, 69367-219 — Hydrochlorothiazide, 69584-361 — Hydrochlorothiazide, 69584-362 — Hydrochlorothiazide, 70010-187 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 70010-188 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 70010-189 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 70436-014 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-015 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-016 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-017 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, +854 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels